The Deficits of Insulin Signal in Alzheimer’s Disease and the Mechanisms of Vanadium Compounds in Curing AD
https://pubmed.ncbi.nlm.nih.gov/37623221/
https://pmc.ncbi.nlm.nih.gov/articles/PMC10453015/
In the earlier stage of AD, anti-diabetes agents such as vanadium compounds were able to prevent or postpone the initiation of tau pathology by modulating the insulin signaling pathway.